Kaur Jasleen, Sehgal Vijay K, Gupta Anita K, Singh Surinder P
Department of Pharmacology, Government Medical College, Patiala, Punjab, India.
Department of Dermatology and Venereal Diseases, Rajindra Hospital, Government Medical College, Patiala, Punjab, India.
Int J Appl Basic Med Res. 2015 May-Aug;5(2):106-10. doi: 10.4103/2229-516X.157155.
The combinations of topical keratolytics with anti-microbials and topical retinoids with antimicrobials are commonly prescribed in the treatment of acne.
The present study was undertaken with the aim of comparing the efficacy and safety of topical benzoyl peroxide and clindamycin versus topical benzoyl peroxide and nadifloxacin versus topical tretinoin and clindamycin in patients of acne vulgaris.
100 patients between 15 and 35 years having ≥2 and ≤30 inflammatory and/or noninflammatory lesions with Investigator's Global Assessment (IGA) score 2/3 were randomly divided into 3 groups. Group A was prescribed benzoyl peroxide 2.5% gel and clindamycin 1% gel, Group B was prescribed benzoyl peroxide 2.5% gel and nadifloxacin 1% cream and Group C was prescribed tretinoin 0.025% and clindamycin 1% gel. Total number of lesions and adverse effects during the treatment were assessed at 0, 4, 8, 12 weeks with IGA score.
There was statistically significant reduction in total number of lesions with better improvement in Group A. Adverse drug reactions during the study showed a better safety profile of Group B which is found to be statistically significant also.
These findings confirm that Group A is more efficacious and Group B is safest among the other two groups.
外用角质剥脱剂与抗菌药物联合使用以及外用维甲酸与抗菌药物联合使用常用于痤疮治疗。
本研究旨在比较外用过氧化苯甲酰和克林霉素、外用过氧化苯甲酰和那氟沙星以及外用维甲酸和克林霉素治疗寻常痤疮患者的疗效和安全性。
100例年龄在15至35岁之间、炎症性和/或非炎症性皮损≥2个且≤30个、研究者整体评估(IGA)评分为2/3的患者被随机分为3组。A组给予2.5%过氧化苯甲酰凝胶和1%克林霉素凝胶,B组给予2.5%过氧化苯甲酰凝胶和1%那氟沙星乳膏,C组给予0.025%维甲酸和1%克林霉素凝胶。在治疗的0、4、8、12周时,根据IGA评分评估皮损总数和不良反应。
A组皮损总数有统计学意义的显著减少,改善情况更好。研究期间的药物不良反应显示B组安全性更好,这也具有统计学意义。
这些发现证实,在其他两组中,A组疗效更佳,B组最安全。